chartexchange

NSTG
NanoString Technologies, Inc.
stockNASDAQ

InactiveFeb 13, 2024
0.1053USD-37.433%(-0.063)23,061,268
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
CEO
R. Bradley Gray
HQ
Seattle, Washington, USA
NSTG Profile

nanostring technologies (nasdaq: nstg) is a publicly held provider of life science tools for translational research and molecular diagnostics. the company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. nanostring technologies provides life science tools for translational research and molecular diagnostic products. the company's ncounter® analysis system, which has been employed in basic and translational research since it was first introduced in 2008 and cited in more than 300 peer-reviewed publications, has also now been applied to diagnostic use as the ncounter dx analysis system. the company's technology offers a cost-effective way to easily profile the expression of hundreds of genes, mirnas, or copy number variations, simultaneously with high sensitivity and precision. the company's technology enables a wide variety of basic research and translational medicine applications, including biomarker discovery and vali

NSTG Performance
PeriodPriceDateChange